Good points by all.
If we're recruiting at a decent pace then we could expect the next patient milestone sometime between mid September and mid October.
- Forums
- ASX - By Stock
- AGN
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-13
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
77.0¢ |
Change
-0.005(0.65%) |
Mkt cap ! $98.63M |
Open | High | Low | Value | Volume |
77.5¢ | 80.0¢ | 77.0¢ | $149.1K | 190.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2820 | 77.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
77.5¢ | 2824 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2820 | 0.770 |
1 | 1307 | 0.765 |
2 | 13128 | 0.760 |
2 | 13755 | 0.755 |
4 | 24183 | 0.750 |
Price($) | Vol. | No. |
---|---|---|
0.775 | 2824 | 1 |
0.790 | 7800 | 1 |
0.800 | 46089 | 1 |
0.830 | 10000 | 1 |
0.840 | 9000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online